Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Examination of B Cell Responses in Human Blood
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Regenerative Medicine Network
University of Leipzig
Information provided by: Regenerative Medicine Network
ClinicalTrials.gov Identifier: NCT00806845
  Purpose

The aim of this study is the assessment B-cell immune responses in HIV-infected individuals.


Condition
HIV Infections

MedlinePlus related topics: AIDS
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Gewinnung Humaner antikörperproduzierender Zellen Aus Dem Blut

Further study details as provided by Regenerative Medicine Network:

Primary Outcome Measures:
  • Antigen specific B-cell responses [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

peripheral blood


Estimated Enrollment: 40
Study Start Date: July 2008
Estimated Study Completion Date: May 2011
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
HIV infected individuals
HIV infected individuals with or without AIDS
Control
HIV negative individuals

Detailed Description:

Groups of patients with different immune competencies will be examined. The impact of HIV infection on immune response will be assessed.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

HIV patients and controls attending specialised clinics, Germany

Criteria

Inclusion Criteria:

  • HIV-infected individuals
  • controls

Exclusion Criteria:

- none

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00806845

Locations
Germany, Sachsen
Universität Leipzig
Leipzig, Sachsen, Germany, 04103
Sponsors and Collaborators
Regenerative Medicine Network
University of Leipzig
Investigators
Study Director: Christian Jassoy, MD Universität Leipzig
  More Information

Responsible Party: Universität Leipzig ( Christian Jassoy MD )
Study ID Numbers: RegMedNet-001
Study First Received: December 10, 2008
Last Updated: January 7, 2009
ClinicalTrials.gov Identifier: NCT00806845  
Health Authority: Germany: Ethics Commission

Keywords provided by Regenerative Medicine Network:
HIV
B-lymphocyte

Study placed in the following topic categories:
Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on January 16, 2009